Close
Clinical Trial of Investigational Medicinal Products (CTIMP)
- PATH study (CIDP)
- PATH extension study (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP))
- Ascorbic acid (Charcot-Marie-Tooth (CMT) disease type 1a)
Cohorts
- Biological Prognostic Factors for IGM Paraproteinemic Anti-Mag Associated Peripheral Neuropathy
- PERINOMS Peripheral Neuropathy outcome measures standardisation study
- Hereditary Sensory Neuropathy type 1 secondary to SPTCL1 and SPTLC2 mutations
Other studies
- Causes of fall and balance impairment in people with neuromuscular diseases
- Strengthening hip muscles
- MRI in IBM and CMT
- Fingolimod (Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP))